INTRODUCTION AND OBJECTIVES:
One of every 10 people will suffer a kidney stone during their lifetime and for every patient with a new kidney stone, half will experience a recurrence within 5-10 years. Nephrolithiasis is a significant source of morbidity in the United States, and its incidence has increased significantly over the last decades. This rise has been attributed to concurrent increasing rates of obesity, which is associated with a nearly 3x risk of developing a urinary stone. To date, the mechanism by which obesity is linked to stone formation has not been elucidated. We aimed to utilize a genomics approach to discover the missing link between these two epidemic diseases.
METHODS: Under IRB approval, we developed a novel tissue acquisition protocol facilitating next-generation RNA-sequencing (RNASeq) analysis for renal papillary tissue samples in patients with nephrolithiasis. To elucidate the mechanism linking obesity with kidney stone formation, we investigated gene expression profiling of kidney stone patients by two RNASeq approaches: comparison between renal papilla tissue with and without the presence of calcified Randall's plaques, and comparison between the papilla, medulla, and cortex regions from within a single recurrent stone forming kidney. We then applied comparative RNAseq analysis between areas of the kidney with differing levels of calcified mineral deposits to identify novel genes associated with urinary stone disease. Analysis results were overlaid between differently expressed genes found in the patient cohort and in the severely lithogenic kidney to identify common genes. We then validated gene hits in a murine model to demonstrate their role as drivers of urinary stone formation.
RESULTS: Overlay of these two RNA-sequencing datasets demonstrated impairment of lipid metabolism in the renal papilla tissue containing Randall's plaques linked to downregulation of fatty acid binding protein (FABP) 4. Immunohistochemistry staining of human kidney specimens confirmed the absence of FABP4 in regions of the kidney with significant Randall's plaques. In a hyperoxaluric stone forming mouse model, microarray analysis of renal tissue confirmed that FABP4 downregulation leads to renal stone formation. CONCLUSIONS: Our study revealed that FABP4 plays an important, previously unrecognized role in kidney stone formation. This represents a novel gene-based mechanism that demonstrates how obesity may drive urinary stone formation via a pathway involving fatty acid metabolism. FABP4 is a potential new target for medical therapies to prevent urinary stone recurrence and warrants additional study. 
The pathogenesis of kidney stones in humans is poorly understood. There are multiple types of kidney stones, and the role of inflammation in promoting specific stone types is not well established. Here, we applied a combination of unbiased omics and quantitative large-scale 3D imaging on kidney stones and papillae from two types of stone forming patients: calcium oxalate and brushite. Our goal was to uncover a specific inflammatory signature that could differentially associate with a specific type of stone disease and infer how they are formed.
METHODS: Kidney stones were obtained from a wellcharacterized cohort of patients in a high volume clinic. Stones were further processed for label free quantitative mass spectrometry to quantify differentially expressed proteins. Papillary biopsies were obtained at the time of percutaneous nephrolithotomy and processed for histology and large scale 3D imaging, as well as transcriptomics. 3D tissue cytometry and analysis was done using Volumetric Tissue Cytometry and Analysis Software (VTEA).
RESULTS: Brushite stones have differentially increased neutrophil proteins such as myeloperoxidase and elastase compared to calcium oxalate evaluated by LC/MS. To determine if this observation is driven by changes in the kidney papillae, we confirmed that the number (6.91 AE1.19% vs. 1.35 AE 0.28%; ; p<0.05) were increased in the papillae from brushite vs. calcium oxalate patients, respectively. To explain how neutrophil proteins are transitioning from the tissue to the stone matrix, we investigated whether Neutrophil Extracellular Trap (NET) formation, whereby neutrophils expel their DNA and their cytoplasmic content, is more common in brushite stones. Indeed, histone citrullination of neutrophils, a marker of NETosis, was increased in brushite compared the calcium oxalate papillae (1.3 AE 0.28% vs. 0.07 AE0.04%; p<0.05). Biopsy total RNA also showed increases in brushite for inflammation and neutrophil activation pathways.
CONCLUSIONS: Our work supports that increased neutrophil infiltration and NETosis may be an important factor in the pathogenesis of brushite stones. We propose that metabolic changes or ascending infections could trigger a hyper-inflammatory response that leads to the release of NET proteins in the urine, which promote brushite stone formation.
